Emami Maryam, Looha Mehdi Azizmohammad, DA-Silva Keith, Shirani Mohammadjavad
College of Dentistry, University of Saskatchewan, Saskatoon, Canada.
Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Evid Based Dent Pract. 2025 Sep;25(3):102143. doi: 10.1016/j.jebdp.2025.102143. Epub 2025 Apr 10.
This systematic review and meta-analysis is the first to evaluate the impact of photobiomodulation therapy (PBMT) on objective and physiological measures of local anesthesia injection pain in children aged 3-12.
This review follows the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA) guidelines and is registered in the International Prospective Register of Systematic Reviews (PROSPERO) under the registration number CRD42024549936. A systematic search was conducted in Embase, PubMed, and the Cochrane Library to locate relevant Randomized Clinical Trials (RCTs) between January 2000 to September 2024. Study screening, data extraction, risk of bias evaluation, and certainty of evidence grading were performed independently by 2 reviewers. Meta-analyses focused on the pain assessment using following measures: Wong-Baker Faces Pain Rating Scale (PRS), Sound, Eye, and Motor Scale (SEM), Face, Legs, Activity, Cry, Consolability Scale (FLACC), and heart rate (HR). Sensitivity analyses were conducted using a leave-one-study-out approach to assess the robustness of the findings, while publication bias and heterogeneity were evaluated through established statistical methods.
Out of 1322 identified studies, 7 RCTs met inclusion criteria. PBMT significantly reduced pain, with moderate certainty, as measured by the objective FLACC scale (SMD = -0.41, 95% CI: -0.72, -0.09, P = .011) and the physiological HR method (SMD = -0.50, 95% CI: -0.86, -0.14, P = .006), demonstrating moderate and no heterogeneity, respectively. However, no statistically significant effect was observed on subjective measures using the PRS (SMD = -0.66, 95% CI: -1.63, 0.32, P = .185) and SEM (SMD = 0.18, 95% CI: -1.09, 1.45, P = .780) scales. Five studies had low risk of bias, and GRADE analysis indicated very low to moderate certainty. Funnel plots showed minimal publication bias, except for slight asymmetry in PRS.
PBMT demonstrates potential as a nonpharmacological method to reduce injection pain in children, as reflected in FLACC and HR outcomes. However, no significant effect of PBMT was observed on the SEM scale. Further research is needed to clarify its impact on subjective pain measures (PRS) and to optimize PBMT protocols.
本系统评价和荟萃分析首次评估了光生物调节疗法(PBMT)对3至12岁儿童局部麻醉注射疼痛的客观和生理指标的影响。
本评价遵循系统评价和荟萃分析方案的首选报告项目(PRISMA)指南,并已在国际前瞻性系统评价注册库(PROSPERO)中注册,注册号为CRD42024549936。在Embase、PubMed和Cochrane图书馆中进行了系统检索,以查找2000年1月至2024年9月期间的相关随机临床试验(RCT)。由两名审阅者独立进行研究筛选、数据提取、偏倚风险评估和证据确定性分级。荟萃分析集中于使用以下指标进行疼痛评估:面部表情疼痛评分量表(PRS)、声音、眼睛和运动量表(SEM)、面部、腿部、活动、哭闹、安慰度量表(FLACC)和心率(HR)。采用逐一剔除研究的方法进行敏感性分析,以评估研究结果的稳健性,同时通过既定的统计方法评估发表偏倚和异质性。
在1322项已识别的研究中,7项RCT符合纳入标准。PBMT显著减轻了疼痛,根据客观的FLACC量表(标准化均数差[SMD]=-0.41,95%可信区间:-0.72,-0.09,P=0.011)和生理HR方法(SMD=-0.50,95%可信区间:-0.86,-0.14,P=0.006)测量,确定性为中等,分别显示中等和无异质性。然而,使用PRS量表(SMD=-0.66,95%可信区间:-1.63,0.32,P=0.185)和SEM量表(SMD=0.18,95%可信区间:-1.09,1.45,P=0.780)未观察到对主观指标有统计学显著影响。五项研究的偏倚风险较低,GRADE分析表明确定性为极低至中等。漏斗图显示除PRS存在轻微不对称外,发表偏倚极小。
PBMT作为一种非药物方法,在减轻儿童注射疼痛方面显示出潜力,这在FLACC和HR结果中得到体现。然而,PBMT对SEM量表未观察到显著影响。需要进一步研究以阐明其对主观疼痛指标(PRS)的影响并优化PBMT方案。